Aberrant NFAT2 signaling in chronic lymphocytic leukemia.

被引：0
|
作者：
Heitmann, Jonas S. [1 ]
Maerklin, Melanie [1 ]
Poljak, Alexandra [1 ]
Hackl, Bettina [1 ]
Stickel, Juliane [1 ]
Kanz, Lothar [1 ]
Kopp, Hans-Georg [1 ]
Wirths, Stefan [1 ]
Mueller, Martin Rudolf [1 ]
机构：
[1] Univ Tubingen, Dept Hematol Oncol & Immunol, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia
    Mueller, David J.
    Wirths, Stefan
    Fuchs, Alexander R.
    Maerklin, Melanie
    Heitmann, Jonas S.
    Sturm, Marc
    Haap, Michael
    Kirschniak, Andreas
    Sasaki, Yoshiteru
    Kanz, Lothar
    Kopp, Hans-Georg
    Mueller, Martin R.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (03) : 531 - 538
  • [2] Wnt signaling in chronic lymphocytic leukemia.
    Lu, DS
    Zhao, YD
    Tawatao, R
    Rosenbach, MD
    Weidinger, G
    Moon, RT
    Leoni, LM
    Corr, M
    Carson, DA
    BLOOD, 2003, 102 (11) : 430A - 430A
  • [3] A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
    Fuchs, Alexander R.
    Maerklin, Melanie
    Heitmann, Jonas S.
    Futterknecht, Stefan
    Haap, Michael
    Wirths, Stefan
    Kopp, Hans-Georg
    Hinterleitner, Clemens
    Doerfel, Daniela
    Mueller, Martin R.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (142):
  • [4] NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
    Maerklin, Melanie
    Heitmann, Jonas S.
    Fuchs, Alexander R.
    Truckenmueller, Felicia M.
    Gutknecht, Michael
    Bugl, Stefanie
    Saur, Sebastian J.
    Lazarus, Juliane
    Kohlhofer, Ursula
    Quintanilla-Martinez, Leticia
    Rammensee, Hans-Georg
    Salih, Helmut R.
    Kopp, Hans-Georg
    Haap, Michael
    Kirschniak, Andreas
    Kanz, Lothar
    Rao, Anjana
    Wirths, Stefan
    Mueller, Martin R.
    NATURE COMMUNICATIONS, 2017, 8
  • [5] NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia
    Melanie Märklin
    Jonas S. Heitmann
    Alexander R. Fuchs
    Felicia M. Truckenmüller
    Michael Gutknecht
    Stefanie Bugl
    Sebastian J. Saur
    Juliane Lazarus
    Ursula Kohlhofer
    Leticia Quintanilla-Martinez
    Hans-Georg Rammensee
    Helmut R. Salih
    Hans-Georg Kopp
    Michael Haap
    Andreas Kirschniak
    Lothar Kanz
    Anjana Rao
    Stefan Wirths
    Martin R. Müller
    Nature Communications, 8
  • [6] Overexpression and aberrant nuclear translocation of NFAT2 in CLL
    Heitmann, J. S.
    Maerkin, M.
    Worbs, D.
    Poljak, A.
    Stickel, J.
    Kanz, L.
    Wirths, S.
    Kopp, H-G
    Mueller, M. R.
    ONKOLOGIE, 2013, 36 : 222 - 222
  • [7] Chronic lymphocytic leukemia.
    Andritsos L.
    Khoury H.
    Current Treatment Options in Oncology, 2002, 3 (3) : 225 - 231
  • [8] NFAT2 determines susceptibility of chronic lymphocytic leukemia cells to constitutive and Rituximab-induced NK cell killing
    Holzmayer, Samuel J.
    Greiner, Sarah M.
    Kaban, Kuebra
    Heitmann, Jonas S.
    Salih, Helmut R.
    Maerklin, Melanie
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Apoptosis in chronic lymphocytic leukemia.
    Giordano, M
    MEDICINA-BUENOS AIRES, 2000, 60 : 12 - 16
  • [10] Fludarabine for chronic lymphocytic leukemia.
    Proctor, SJ
    Mounter, P
    Summerfield, GP
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15): : 1167 - 1167
12345